A detailed history of Provident Investment Management, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Provident Investment Management, Inc. holds 2,647 shares of JNJ stock, worth $386,541. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,647
Previous 2,932 9.72%
Holding current value
$386,541
Previous $459,000 8.93%
% of portfolio
0.04%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $44,237 - $46,380
-285 Reduced 9.72%
2,647 $418,000
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $16,744 - $18,271
-115 Reduced 3.77%
2,932 $459,000
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $7,787 - $8,724
-50 Reduced 1.61%
3,047 $474,000
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $176,426 - $210,543
1,168 Added 60.55%
3,097 $480,000
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $5,126 - $5,753
32 Added 1.69%
1,929 $340,000
Q4 2020

Feb 10, 2021

SELL
$137.11 - $157.38 $239,942 - $275,415
-1,750 Reduced 47.98%
1,897 $299,000
Q3 2020

Nov 05, 2020

SELL
$140.38 - $153.83 $58,117 - $63,685
-414 Reduced 10.19%
3,647 $543,000
Q4 2019

Feb 10, 2020

BUY
$127.5 - $146.44 $52,785 - $60,626
414 Added 11.35%
4,061 $592,000
Q3 2019

Nov 06, 2019

SELL
$126.95 - $142.14 $6,347 - $7,106
-50 Reduced 1.35%
3,647 $472,000
Q1 2019

May 13, 2019

SELL
$125.72 - $139.79 $402,304 - $447,328
-3,200 Reduced 46.4%
3,697 $517,000
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $389,056 - $457,216
-3,200 Reduced 31.69%
6,897 $953,000
Q2 2018

Aug 09, 2018

BUY
$119.4 - $131.76 $498,256 - $549,834
4,173 Added 70.44%
10,097 $1.23 Million
Q4 2017

Feb 06, 2018

BUY
$131.22 - $143.62 $229,635 - $251,335
1,750 Added 41.93%
5,924 $828,000
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $540,407 - $565,076
4,174
4,174 $543,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Provident Investment Management, Inc. Portfolio

Follow Provident Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Provident Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Provident Investment Management, Inc. with notifications on news.